Answers are grounded in this paper and cite their sources.
Irreversible post-translational modifications provide a potential means to impose persistent changes in protein function, yet their controlled generation inside living cells remains challenging. Here, we develop an ultrasound-responsive potassium sodium niobate–gold (KNN@Au) piezoelectric nanoheterojunction functionalized with hyaluronic acid (KNN@Au-HA) to enable in situ terminal protein sulfonation. Under ultrasound excitation, the dynamic modulation of KNN polarization generates a piezo-potential that facilitates interfacial charge separation and electron transfer, promoting the single-electron reduction of O2 to •O2–. Meanwhile, Au–S coordination positions thiol substrates in close proximity to the catalytic surface, facilitating the subsequent multistep oxidation of cysteine thiols to the terminal −SO3H state. Using this platform, we identify ribosomal protein RPL32 as a functionally relevant sulfonation target and resolve sulfonation at Cys96 by mass spectrometry. This modification disrupts ribosomal proteostasis, induces NRF2 nuclear translocation and stress signaling, and converts colorectal cancer cells into a competitive “loser” state that undergoes neighbor-dependent apoptotic elimination. In HCT116 xenograft-bearing mice, ultrasound-activated KNN@Au-HA suppresses colorectal tumor growth; analysis of patient-derived single-cell transcriptomic data reveals RPL32 upregulation as a hallmark of the malignant “winner” state, establishing a functional match between this competition therapy and colorectal cancer. Together, these findings demonstrate that piezocatalytic protein modification can chemically reprogram cellular competitive fitness without genome editing, providing a proof of concept for nongenetic competition therapy against cancer.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: